VUITY Drug Patent Profile

✉ Email this page to a colleague

When do Vuity patents expire, and what generic alternatives are available?

Vuity is a drug marketed by Abbvie and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has thirty-two patent family members in twenty-three countries.

The generic ingredient in VUITY is pilocarpine hydrochloride. There are twelve drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the pilocarpine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Vuity

A generic version of VUITY was approved as pilocarpine hydrochloride by PADAGIS US on November 16^th, 2004.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for VUITY?
What are the global sales for VUITY?
What is Average Wholesale Price for VUITY?

Summary for VUITY

International Patents:	32
US Patents:	2
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	75
Patent Applications:	3,807
Drug Prices:	Drug price information for VUITY
What excipients (inactive ingredients) are in VUITY?	VUITY excipients list
DailyMed Link:	VUITY at DailyMed

Drug patent expirations by year for VUITY

Pharmacology for VUITY

Drug Class	Cholinergic Receptor Agonist
Mechanism of Action	Cholinergic Agonists Cholinergic Muscarinic Agonists

Paragraph IV (Patent) Challenges for VUITY

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
VUITY	Ophthalmic Solution	pilocarpine hydrochloride	1.25%	214028	1	2022-12-30

US Patents and Regulatory Information for VUITY

VUITY is protected by six US patents and two FDA Regulatory Exclusivities.

Patents protecting VUITY

Presbyopia treatments
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF PRESBYOPIA IN ADULTS BY ADMINISTRATION OF PILOCARPINE HCI FORMULATION TWICE DAILY

Presbyopia treatments
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF PRESBYOPIA IN ADULTS BY ADMINISTRATION OF PILOCARPINE HCI FORMULATION ONCE DAILY

Presbyopia treatments
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: USE OF VUITY FOR THE TREATMENT OF PRESBYOPIA IN ADULTS

Presbyopia treatments
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF PRESBYOPIA IN ADULTS BY ADMINISTRATION OF PILOCARPINE HCI FORMULATION ONCE DAILY

Presbyopia treatments
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: USE OF VUITY FOR THE TREATMENT OF PRESBYOPIA IN ADULTS

FDA Regulatory Exclusivity protecting VUITY

ADDITION OF SECOND DOSE FOR TREATMENT OF PRESBYOPIA IN ADULTS
Exclusivity Expiration: ⤷ Sign Up

NEW PRODUCT
Exclusivity Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abbvie	VUITY	pilocarpine hydrochloride	SOLUTION;OPHTHALMIC	214028-001	Oct 28, 2021		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Abbvie	VUITY	pilocarpine hydrochloride	SOLUTION;OPHTHALMIC	214028-001	Oct 28, 2021		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Abbvie	VUITY	pilocarpine hydrochloride	SOLUTION;OPHTHALMIC	214028-001	Oct 28, 2021		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Abbvie	VUITY	pilocarpine hydrochloride	SOLUTION;OPHTHALMIC	214028-001	Oct 28, 2021		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for VUITY

See the table below for patents covering VUITY around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
China	112272558	盐酸毛果芸香碱用于治疗眼部病症的用途 (PRESBYOPIA TREATMENTS)	⤷ Sign Up
Australia	2019261598	Use of pilocarpine hydrochloride for the treatment of ocular conditions	⤷ Sign Up
Mexico	2020011301	USO DE CLORHIDRATO DE PILOCARPINA PARA EL TRATAMIENTO DE AFECCIONES OCULARES. (USE OF PILOCARPINE HYDROCHLORIDE FOR THE TREATMENT OF OCULAR CONDITIONS.)	⤷ Sign Up
Lithuania	3681500		⤷ Sign Up
South Korea	20230079489	안구 증상의 치료를 위한 필로카르핀 염산염의 용도 (USE OF PILOCARPINE HYDROCHLORIDE FOR THE TREATMENT OF OCULAR CONDITIONS)	⤷ Sign Up
Spain	2920803		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration